Compostions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells

a nucleic acid and cell technology, applied in the field of nucleic acid delivery into cells, can solve the problems of limited nucleic acid delivery techniques, poor efficiency, toxicity of delivery reagents,

Inactive Publication Date: 2006-02-23
MDRNA
View PDF8 Cites 79 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There remains a long-standing need in the art for better tools and methods to deliver siRNAs and other small inhibitory nucleic acids (siNAs) into cells, partic...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compostions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells
  • Compostions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells
  • Compostions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells

Examples

Experimental program
Comparison scheme
Effect test

example 1

Production and Characterization of Compositions Comprising a siRNA Complexed with a Polynucleotide Delivery-Enhancing Polypeptide

[0132] To form complexes between candidate siRNAs and polynucleotide delivery-enhancing polypeptides of the invention, an adequate amount of siRNA is combined with a pre-determined amount of polynucleotide delivery-enhancing polypeptide, for example in Opti-MEM® cell medium (Invitrogen), in defined ratios and incubated at room temperature for about 10-30 min. Subsequently a selected volume, e.g., about 50 μl, of this mixture is brought into contact with target cells and the cells are incubated for a predetermined incubation period, which in the present example was about 2 hr. The siNA / peptide mixture can optionally include cell culture medium or other additives such as fetal bovine serum. For H3, H4 and H2b, a series of experiments was performed to complex these polynucleotide delivery-enhancing polypeptides with siRNA in different ratios. Generally this ...

example 2

Production and Characterization of Compositions Comprising a siRNA Comjugated With a TAT-HA Polynucleotide Delivery-Enhancing Polypeptide

[0171] The present example describes the synthesis and uptake activity of specific peptides covalently conjugated to one strand of a siRNA duplex. These conjugates efficiently deliver siRNA into the cytoplasm and mediate knockdown of desired target genes.

Peptide Synthesis

[0172] Peptides were synthesized by solid-phase Fmoc chemistry on CLEAR-amide resin using a Rainin Symphony synthesizer. Coupling steps were performed using 5 equivalents of HCTU and Fmoc amino acid with an excess of N-methylmorpholine for 40 minutes. Fmoc removal was accomplished by treating the peptide resin with 20% piperidine in DMF for two 10 minutes cycles. Upon completion of the entire peptide, the Fmoc group was removed with piperidine and washed extensively with DMF. Maleimido modified peptides were prepared by coupling 3.0 equivalents of 3-maleimidopropionic acid and ...

example 3

Screening of siRNA / Delivery Peptide Complexes Demonstrates Efficient Induction of siRNA Uptake in 9L / LacZ Cells by a Diverse Assemblage of Rationally-Designed Polynucleotide Delivery-Enhancing Polypeptides

[0179] The present example provides additional evidence that a broad and diverse assemblage of rationally-designed polynucleotide delivery-enhancing polypeptides of the invention induce or enhance siRNA uptake when complexed with siRNAs

[0180] Approximately 10,000 9L / lacZ cells were plated per well in flat-bottom 96-well plates so that they would be ˜50% confluent the next day at the time of transfection. FAM-labeled siRNA and peptides were diluted in Opti-MEM® media (Invitrogen) at 2-fold the final concentration. Equal volumes of siRNA and peptide were mixed and allowed to complex 5-10 minutes at room temperature and then 50 μL added to cells, previously washed with PBS. Cells were transfected for 3 hours at 37° C., 5% CO2. Cells were washed with PBS, treated with trypsin and the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Dimensionless propertyaaaaaaaaaa
Volumeaaaaaaaaaa
Volumeaaaaaaaaaa
Login to view more

Abstract

Polynucleotide delivery-enhancing polypeptides are admixed or complexed with, or conjugated to, nucleic acids for enhancing delivery the nucleic acids into cells. The transported nucleic acids are active in target cells as small inhibitory nucleic acids (siNAs) that modulate expression of target genes, mediated at least in part by RNA interference (RNAi). The siNA/polypeptide compositions and methods of the invention provide effective tools to modulate gene expression and alter phenotype in mammalian cells, including by altering phenotype in a manner that eliminates disease symptoms or alters disease potential in targeted cells or subject individuals to which the siNA/polypeptide compositions are administered.

Description

CROSS REFERENCES TO RELATED APPLICATIONS [0001] This application claims the priority benefit of U.S. Provisional Patent Application No. 60 / 568,027, filed May 4, 2004, U.S. Provisional Patent Application No. 60 / 570,512, filed May 12, 2004, U.S. Provisional Patent Application No. 60 / 570,513, filed May 12, 2004, U.S. Provisional Patent Application No. 60 / 613,416, filed Sep. 27, 2004, U.S. Provisional Patent Application No. 60 / 656,572 filed Feb. 25, 2005, and U.S. Provisional Patent Application No. 60 / 667,833, filed Apr. 1, 2005, the disclosures of which are incorporated herein by reference in their entirety.TECHNICAL FIELD [0002] The invention relates to methods and compositions for delivering nucleic acids into cells. More specifically, the invention relates to procedures and preparations for delivering double-stranded polynucleotides into cells to modify expression of target genes to alter a phenotype, such as a disease state or potential, of the cells. BACKGROUND OF THE INVENTION [0...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K48/00C12N15/85C12N15/11C12N15/113
CPCC07K14/001C07K14/43572C07K14/47C12N15/111C12N15/1136A61K2121/00C12N2310/14C12N2310/3513C12N2320/32A61K47/48246C12N15/87A61K47/64A61P17/06A61P19/02A61P29/00A61P37/00A61P43/00A61K31/7105A61K48/00C12N15/85
Inventor CHEN, LISHANCUI, KUNYUANCHEN, YUCHINGMAYER, SASHA J.
Owner MDRNA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products